February 28, 2021
https://doi.org/10.23999/j.dtomp.2021.2.2
J Diagn Treat Oral Maxillofac Pathol 2021;5:15–9.
Under a Creative Commons license
Tymofieiev OO, Ushko NO, Fesenko II, Maksymcha SV, Yarifa MO, Ripa VM, Myroshnyk AO, Savytskyi OO, Dubichenko SI, Blinova VP, Uharska OA, Serga OO. Prevention of inflammatory complications in fractures of alveolar processes of the jaw. J Diagn Treat Oral Maxillofac Pathol 2021;5(2):20–31.
Purpose: To determine the effectiveness of the nonsteroidal anti-inflammatory drug “Tantum Verde” in patients with fractures of the alveolar processes of the maxilla and mandible, to evaluate its effectiveness for the prevention of inflammatory complications.
Methods: Clinical and laboratory examination of 129 patients with fractures of the alveolar processes of the jaws.
Results: Based on the results of the patients examination with open fractures of the jaws. It was found that the analgesic, anti-inflammatory and deodorant efficacy of the nonsteroidal anti-inflammatory drug “Tantum Verde” is significantly higher than traditional therapy, and also has a smaller number of inflammatory complications.
Conclusions: The use of the nonsteroidal anti-inflammatory drug “Tantum Verde” made it possible to significantly reduce the number of inflammatory complications and reduce the treatment duration of patients.
It was established that the drug “Tantum Verde” is an effective analgesic and anti-inflammatory drug and can be recommended for the treatment of patients with fractures of the alveolar processes of the jaws.